2
|
Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows A, Marina N, Kadan-Lottick N, Leisenring W, Robison LL. Prevalence and severity of chronic diseases in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.9] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- K. C. Oeffinger
- Univ of Texas Southwestern Medcl Ctr, Dallas, TX; Univ of Minnesota, Minneapolis, MN; Memorial Sloan-Kettering Cancer Ctr, New York, NY; Fred Hutchinson Cancer Research Ctr, Seattle, WA; St. Jude Children’s Research Hosp, Memphis, TN; Univ of Pennsylvania, Philadelphia, PA; Stanford Univ Medcl Ctr, Palo Alto, CA; Yale Univ, New Haven, CT
| | - A. C. Mertens
- Univ of Texas Southwestern Medcl Ctr, Dallas, TX; Univ of Minnesota, Minneapolis, MN; Memorial Sloan-Kettering Cancer Ctr, New York, NY; Fred Hutchinson Cancer Research Ctr, Seattle, WA; St. Jude Children’s Research Hosp, Memphis, TN; Univ of Pennsylvania, Philadelphia, PA; Stanford Univ Medcl Ctr, Palo Alto, CA; Yale Univ, New Haven, CT
| | - C. A. Sklar
- Univ of Texas Southwestern Medcl Ctr, Dallas, TX; Univ of Minnesota, Minneapolis, MN; Memorial Sloan-Kettering Cancer Ctr, New York, NY; Fred Hutchinson Cancer Research Ctr, Seattle, WA; St. Jude Children’s Research Hosp, Memphis, TN; Univ of Pennsylvania, Philadelphia, PA; Stanford Univ Medcl Ctr, Palo Alto, CA; Yale Univ, New Haven, CT
| | - T. Kawashima
- Univ of Texas Southwestern Medcl Ctr, Dallas, TX; Univ of Minnesota, Minneapolis, MN; Memorial Sloan-Kettering Cancer Ctr, New York, NY; Fred Hutchinson Cancer Research Ctr, Seattle, WA; St. Jude Children’s Research Hosp, Memphis, TN; Univ of Pennsylvania, Philadelphia, PA; Stanford Univ Medcl Ctr, Palo Alto, CA; Yale Univ, New Haven, CT
| | - M. M. Hudson
- Univ of Texas Southwestern Medcl Ctr, Dallas, TX; Univ of Minnesota, Minneapolis, MN; Memorial Sloan-Kettering Cancer Ctr, New York, NY; Fred Hutchinson Cancer Research Ctr, Seattle, WA; St. Jude Children’s Research Hosp, Memphis, TN; Univ of Pennsylvania, Philadelphia, PA; Stanford Univ Medcl Ctr, Palo Alto, CA; Yale Univ, New Haven, CT
| | - A. Meadows
- Univ of Texas Southwestern Medcl Ctr, Dallas, TX; Univ of Minnesota, Minneapolis, MN; Memorial Sloan-Kettering Cancer Ctr, New York, NY; Fred Hutchinson Cancer Research Ctr, Seattle, WA; St. Jude Children’s Research Hosp, Memphis, TN; Univ of Pennsylvania, Philadelphia, PA; Stanford Univ Medcl Ctr, Palo Alto, CA; Yale Univ, New Haven, CT
| | - N. Marina
- Univ of Texas Southwestern Medcl Ctr, Dallas, TX; Univ of Minnesota, Minneapolis, MN; Memorial Sloan-Kettering Cancer Ctr, New York, NY; Fred Hutchinson Cancer Research Ctr, Seattle, WA; St. Jude Children’s Research Hosp, Memphis, TN; Univ of Pennsylvania, Philadelphia, PA; Stanford Univ Medcl Ctr, Palo Alto, CA; Yale Univ, New Haven, CT
| | - N. Kadan-Lottick
- Univ of Texas Southwestern Medcl Ctr, Dallas, TX; Univ of Minnesota, Minneapolis, MN; Memorial Sloan-Kettering Cancer Ctr, New York, NY; Fred Hutchinson Cancer Research Ctr, Seattle, WA; St. Jude Children’s Research Hosp, Memphis, TN; Univ of Pennsylvania, Philadelphia, PA; Stanford Univ Medcl Ctr, Palo Alto, CA; Yale Univ, New Haven, CT
| | - W. Leisenring
- Univ of Texas Southwestern Medcl Ctr, Dallas, TX; Univ of Minnesota, Minneapolis, MN; Memorial Sloan-Kettering Cancer Ctr, New York, NY; Fred Hutchinson Cancer Research Ctr, Seattle, WA; St. Jude Children’s Research Hosp, Memphis, TN; Univ of Pennsylvania, Philadelphia, PA; Stanford Univ Medcl Ctr, Palo Alto, CA; Yale Univ, New Haven, CT
| | - L. L. Robison
- Univ of Texas Southwestern Medcl Ctr, Dallas, TX; Univ of Minnesota, Minneapolis, MN; Memorial Sloan-Kettering Cancer Ctr, New York, NY; Fred Hutchinson Cancer Research Ctr, Seattle, WA; St. Jude Children’s Research Hosp, Memphis, TN; Univ of Pennsylvania, Philadelphia, PA; Stanford Univ Medcl Ctr, Palo Alto, CA; Yale Univ, New Haven, CT
| |
Collapse
|
3
|
Kadan-Lottick N, Marshall JA, Barón AE, Krebs NF, Hambidge KM, Albano E. Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998. J Pediatr 2001; 138:898-904. [PMID: 11391336 DOI: 10.1067/mpd.2001.113102] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE We investigated whether previous reports of reduced bone mineral density after management for childhood acute lymphoblastic leukemia (chALL) were confirmed in a more recently treated cohort. STUDY DESIGN In a cross-sectional study 75 subjects who were given the diagnosis of chALL between January 1, 1991, and December 31, 1997 (69% standard, 31% high risk), at Denver Children's Hospital and who were 11 to 82 months post-diagnosis with no history of relapse, secondary malignancy, or transplant underwent whole body areal bone mineral densitometry (BMD(A) expressed as age- and sex-standardized z scores), a food frequency questionnaire, and a weight-bearing activity survey. RESULTS Overall, the mean whole body BMD(A) z score was normal (+0.22 +/- 0.96). A significant positive association was found with whole body BMD(A) z score and years elapsed since the beginning of maintenance (linear regression coefficient = +0.2 Deltaz score/year; 95% CI = 0.09 to 0.3) after adjustment was done for risk status/age category, history of cranial radiation, and total days hospitalized. No association was found with high risk/older age at diagnosis, nutrient intake, chemotherapy dosage, or weight-bearing activity. CONCLUSION Contrary to previous reports in which cranial radiation and longer hospitalizations were prominent components of therapy, our study suggests that more recently treated patients with chALL do not have persistent abnormalities of bone mineral density after completion of therapy.
Collapse
Affiliation(s)
- N Kadan-Lottick
- Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Colorado Health Sciences Center, Denver, CO, USA
| | | | | | | | | | | |
Collapse
|